Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
about
Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin.Macroprolactin; a frequent cause of misdiagnosed hyperprolactinemia in clinical practice.Serum prolactin and macroprolactin levels among outpatients with major depressive disorder following the administration of selective serotonin-reuptake inhibitors: a cross-sectional pilot studyNeuroendocrine causes of amenorrhea--an update.Clinical and radiological features of patients with macroprolactinaemia.Clinical relevance of macroprolactin.Ultrafiltration - an alternative method to polyethylene glycol precipitation for macroprolactin detection.Macroprolactinemia in a patient with invasive macroprolactinoma: a case report and minireview.Frequency of Macroprolactinemia in Hyperprolactinemic Women Presenting with Menstrual Irregularities, Galactorrhea, and/or Infertility: Etiology and Clinical Manifestations.Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.Macroprolactinemia in hyperprolactinemic infertile women.Prevalence of hyperprolactinaemia in female premenopausal blood donors.Clinical and radiological findings in macroprolactinemia.Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed.Reference ranges for serum total and monomeric prolactin for the current generation Abbott Architect assay.Different stability of free and complexed prostate-specific antigen in serum in relation to specimen handling and storage conditions.
P2860
Q34211804-5E0C8116-2FDF-4EE0-8EC4-AEC0E05C2A1FQ34910315-F3AF2F99-34F7-46C7-9EB2-97F8F9566FC6Q35061572-D65CC2C3-6C08-454E-B140-E95718A9F3E8Q35096850-026EB407-BC3A-4D6A-9960-8D555375FCB0Q35200036-F70FF0BB-1DFB-426E-A2A3-E4AD668B84B3Q36155952-25A6F70D-01A6-4AA9-8315-91F8DB1ABC50Q36220645-4630BB4C-A2AC-4F9D-BACC-58FE3CA4DBB0Q36582461-616BD935-339D-41DE-B075-8395EF3F8D22Q37249881-6ECB50A8-0DD6-4A14-B260-2E66B23444E8Q40702833-B6F8ABA3-116B-46BA-B08B-26046E0EFB38Q44014414-33804838-4A03-4AF4-8B28-09C10BEEB04DQ44151202-E6184946-66BE-4D89-80EB-70B4C71C30BBQ48763949-9F228D55-56F9-4FFC-B137-95CA35786CFFQ48871484-62B7322C-9020-4882-B975-A63526778794Q51124317-DC90E9E8-AE94-4E55-B3A8-8BF9C0B7E9DBQ52966352-8CC07352-BB71-42B0-B866-3A7A96BCC9C9
P2860
Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Macroprolactinaemia: validatio ...... acterization of the condition.
@ast
Macroprolactinaemia: validatio ...... acterization of the condition.
@en
type
label
Macroprolactinaemia: validatio ...... acterization of the condition.
@ast
Macroprolactinaemia: validatio ...... acterization of the condition.
@en
prefLabel
Macroprolactinaemia: validatio ...... acterization of the condition.
@ast
Macroprolactinaemia: validatio ...... acterization of the condition.
@en
P2860
P1476
Macroprolactinaemia: validatio ...... acterization of the condition.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2265.1999.00757.X
P577
1999-07-01T00:00:00Z